Twist Bioscience (TWST) Retained Earnings (2018 - 2026)

Twist Bioscience (TWST) has reported Retained Earnings for 9 consecutive years, with -$1.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Retained Earnings fell 179.5% year-over-year to -$1.4 billion; the TTM figure through Mar 2026 stood at -$1.4 billion (down 179.5% YoY), while the FY2025 annual figure was $1.8 billion, up 343617.82% from the prior year.
• Retained Earnings declined to -$1.4 billion in Q1 2026 per TWST's latest filing, from -$1.4 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $1.8 billion in Q3 2025 and bottomed at -$1.4 billion in Q1 2026.
• Historically, Retained Earnings has averaged $193.3 million across 5 years, with a median of -$565000.0 in 2023.
• Annual changes were most pronounced in 2024 — Retained Earnings plunged 225298.58% — and 2025, when it surged 343617.82%.
• Twist Bioscience's Retained Earnings stood at -$870.2 million in 2022, then surged by 99.94% to -$565000.0 in 2023, then slumped by 225298.58% to -$1.3 billion in 2024, then declined by 6.01% to -$1.4 billion in 2025, then dropped by 3.26% to -$1.4 billion in 2026.
• Business Quant data shows TWST's Retained Earnings at -$1.4 billion in Q1 2026, -$1.4 billion in Q4 2025, and $1.8 billion in Q3 2025.